OSLO (Reuters) – Norway will delay its decision on whether to resume the use of AstraZeneca’s COVID-19 vaccine, broadcaster TV2 reported on Friday.
Authorities suspended the rollout of the vaccine two weeks ago after several younger inoculated people were hospitalised, some of whom later died.
(Reporting by Terje Solsvik, editing by Gwladys Fouche)
